KLWA
Kelly Lawrence W & Associates Portfolio holdings
AUM
$382M
This Quarter Return
+13.56%
1 Year Return
+13.86%
3 Year Return
+61.56%
5 Year Return
+124.1%
10 Year Return
+368.26%
AUM
$608M
AUM Growth
+$608M
(+12%)
Cap. Flow
+$4.12M
Cap. Flow
% of AUM
0.68%
Top 10 Holdings %
Top 10 Hldgs %
38.67%
Holding
137
New
3
Increased
41
Reduced
17
Closed
2
Top Buys
| 1 |
TWO.PRE
Two Harbors Investment Corp. 7.50% Series E Cumulative Redeemable Preferred Stock
TWO.PRE
|
$1.68M |
| 2 |
B&G Foods
BGS
|
$683K |
| 3 |
Schlumberger
SLB
|
$343K |
| 4 |
Cisco
CSCO
|
$336K |
| 5 |
WELLS FARGO 7.5% NON CUMV PERP CONV
WFC.PRL
|
$276K |
Top Sells
| 1 |
CYS.PRB
CYS Investments, Inc.
CYS.PRB
|
$1.54M |
| 2 |
Broadridge
BR
|
$192K |
| 3 |
Roper Technologies
ROP
|
$188K |
| 4 |
PayPal
PYPL
|
$188K |
| 5 |
Advanced Micro Devices
AMD
|
$102K |
Sector Composition
| 1 | Technology | 26.12% |
| 2 | Healthcare | 19.22% |
| 3 | Financials | 17.32% |
| 4 | Consumer Discretionary | 9.09% |
| 5 | Communication Services | 7.34% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
AGN
26
DELISTED
Allergan plc
AGN
| $10.6M | 1.75% |
55,809
+385
| +0.7% | +$73.3K |
|
27
Regeneron Pharmaceuticals
REGN
$61.5B
| $10.4M | 1.71% |
25,660
+435
| +2% | +$176K |
|
28
Merck
MRK
$210B
| $9.86M | 1.62% |
139,010
+700
| +0.5% | +$49.7K |
|
29
Salesforce
CRM
$245B
| $9.14M | 1.5% |
57,475
+1,000
| +2% | +$159K |
|
30
Edwards Lifesciences
EW
$47.8B
| $8.55M | 1.41% |
49,100
| – | – |
|
31
Chevron
CVX
$324B
| $8.35M | 1.37% |
68,300
-346
| -0.5% | -$42.3K |
|
32
JPMorgan Chase
JPM
$829B
| $7.9M | 1.3% |
70,010
+100
| +0.1% | +$11.3K |
|
|
33
Cisco
CSCO
$274B
| $7.8M | 1.28% |
160,276
+6,900
| +4% | +$336K |
|
34
Alphabet (Google) Class C
GOOG
$2.58T
| $7.07M | 1.16% |
5,927
-15
| -0.3% | -$17.9K |
|
35
Halliburton
HAL
$19.4B
| $5.62M | 0.92% |
138,550
-125
| -0.1% | -$5.07K |
|
36
Applied Materials
AMAT
$128B
| $3.82M | 0.63% |
98,805
| – | – |
|
37
Aflac
AFL
$57.2B
| $3.37M | 0.55% |
71,618
+350
| +0.5% | +$16.5K |
|
38
Procter & Gamble
PG
$368B
| $3.3M | 0.54% |
39,655
+200
| +0.5% | +$16.6K |
|
39
Gilead Sciences
GILD
$140B
| $2.37M | 0.39% |
30,705
+1,100
| +4% | +$84.9K |
|
40
AbbVie
ABBV
$372B
| $2.37M | 0.39% |
25,045
| – | – |
|
41
3M
MMM
$82.8B
| $2.23M | 0.37% |
10,559
+767
| +8% | +$162K |
|
42
Vertex Pharmaceuticals
VRTX
$100B
| $2.18M | 0.36% |
11,327
-500
| -4% | -$96.4K |
|
|
43
WELLS FARGO 7.5% NON CUMV PERP CONV
WFC.PRL
$4.82B
| $2.17M | 0.36% |
1,690
+215
| +15% | +$276K |
|
44
Exxon Mobil
XOM
$487B
| $1.93M | 0.32% |
22,695
+454
| +2% | +$38.6K |
|
|
RDS.A
45
DELISTED
Royal Dutch Shell PLC ADS Class A
RDS.A
| $1.88M | 0.31% |
27,574
| – | – |
|
|
46
B&G Foods
BGS
$361M
| $1.73M | 0.28% |
63,000
+24,900
| +65% | +$683K |
|
47
Verizon
VZ
$186B
| $1.7M | 0.28% |
31,775
+1,100
| +4% | +$58.7K |
|
|
TWO.PRE
48
DELISTED
Two Harbors Investment Corp. 7.50% Series E Cumulative Redeemable Preferred Stock
TWO.PRE
| $1.68M | 0.28% |
+69,050
| New | +$1.68M |
|
49
DuPont de Nemours
DD
$32.2B
| $1.45M | 0.24% |
22,575
| – | – |
|
50
Microsoft
MSFT
$3.77T
| $1.15M | 0.19% |
10,072
+1,434
| +17% | +$164K |
|